Developments Model Medicines unveils AI-driven pipeline breakthrough; demonstrates end-to-end drug discovery capabilities Closely held Model Medicines has announced the unveiling of a generative AI-driven, multi-modal therapeutic pipeline breakthrough, showcasing its end-to-end drug discovery capabilities for novel target discovery... January 28, 2025